Business Context and Reporting Period
Company: DENTSPLY SIRONA Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 24, 2025
Event: Entry into material definitive agreements to amend existing debt facilities and note purchase agreements.
Key Financial Metrics and Covenant Changes
The filing details amendments to the Company's revolving credit facility and three separate Note Purchase Agreements. The primary financial impact is the restructuring of debt covenants to ensure compliance. The filing does not provide current revenue, profit, cash flow, or total debt balances.
- Total Leverage Ratio Covenant: Replaces the previous 0.65 threshold. New limits are:
- 4.25x for periods ending Dec 31, 2025 through June 30, 2026.
- 4.00x for periods ending Sept 30, 2026 through Dec 31, 2026.
- 3.75x for periods ending March 31, 2027 through June 30, 2027.
- 3.50x for periods ending Sept 30, 2027 and thereafter.
- Senior Leverage Ratio Covenant: Replaces the previous 0.6 senior debt to capitalization ratio. New limits are:
- 3.25x for periods ending Dec 31, 2025 through June 30, 2026.
- 3.00x for periods ending Sept 30, 2026 through Dec 31, 2026.
- 2.75x for periods ending March 31, 2027 through June 30, 2027.
- 2.50x for periods ending Sept 30, 2027 and thereafter.
- EBITDA Definition Modification: Limits add-backs for efficiency initiative charges incurred between March 31, 2025, and December 31, 2026:
- Q1 2025 (ended March 31): $25,000,000.
- Q2 2025 (ended June 30): $5,000,000.
- Q3 2025 (ended Sept 30): $17,000,000.
- Q4 2025 through Q4 2026: $75,000,000 aggregate.
- Debt Definition Modification: Obligations under swap agreements are now excluded from the "Debt" calculation for leverage ratios.
- Restricted Payments: A new covenant prohibits Restricted Payments, subject to specified exceptions.
- Interest Rate Adjustments: Provisions added to adjust interest rates if the total leverage ratio exceeds specified thresholds.
Material Changes Versus Prior Period
The amendments represent a significant relaxation of financial covenants compared to the prior terms, which required a leverage ratio not to exceed 0.65 and a senior debt to capitalization ratio not to exceed 0.6. The new terms allow for significantly higher leverage ratios (up to 4.25x) to accommodate the Company's current financial position and efficiency initiatives.
Guidance, Outlook, and Risks
Management Commentary: The revised terms are intended to allow the Company to maintain compliance with its debt covenants in all material respects.
Risks: The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially due to risks and uncertainties outside the Company's control. Investors are directed to the "Risk Factors" section of the most recent Form 10-K for a complete discussion of potential risks.
Investor Verification Checklist
- Verify the Company's current Consolidated Debt and Consolidated EBITDA to assess compliance with the new 4.25x Total Leverage Ratio threshold for the quarter ending December 31, 2025.
- Review the specific "efficiency initiatives" referenced in the EBITDA add-back limitations to understand the nature of the expenses being capitalized or excluded.
- Confirm the status of any "Restricted Payments" (e.g., dividends, share repurchases) under the new prohibition covenant.
- Examine the attached Exhibits (4.1 through 4.4) for the full legal text of the amendments and specific interest rate adjustment triggers.
- Check subsequent filings for any updates on the Company's leverage ratio performance against the new stepped-down targets for 2026 and 2027.